Clinical Trial Update: 0.005% Latanoprost Gel for Nonsegmental Vitiligo [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating 0.005% latanoprost gel for nonsegmental vitiligo (macular depigmentation) is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vitiligo

Drugs mentioned

• Latanoprost Gel (latanoprost)

Snippet

Sponsor: Universitas Padjadjaran | Conditions: Vitiligo - Macular Depigmentation | Phase 2 | Status: NOT_YET_RECRUITING